ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 2033 • 2012 ACR/ARHP Annual Meeting

    Infliximab Is an Effective Therapy in Pediatric Renal Sarcoidosis

    Elisa Wershba1, Laura Lewandowski1, Heather Van Mater2 and C. Egla Rabinovich1, 1Pediatric Rheumatology, Duke University Medical Center, Durham, NC, 2Duke Pediatric Rheumatology, Duke University Medical Center, Durham, NC

    Background/Purpose:   Renal sarcoidosis is an unusual form of a rare multisystem disease, and there is little data to guide therapy. The cytokines implicated in…
  • Abstract Number: 2034 • 2012 ACR/ARHP Annual Meeting

    Magnetic Resonance Imaging Is a Reliable Tool to Monitor Chronic Non-Bacterial Osteomyelitis in Children

    Grazia Minardo1, Giulia Zanon1, Simone Corradin2, Pietro Zucchetta3, Giorgia Martini4, Fabio Vittadello1 and Francesco Zulian5, 1Department of Pediatrics, University of Padua, Padua, Italy, 2Institute of Radiology, University of Padua, Padua, Italy, 3Department of Nuclear Medicine, University of Padua, Padua, Italy, 4Department of Pediatrics,, University of Padua, Padua, Italy, 5Department of Pediatrics, University of Padua, Padova, Italy

    Background/Purpose: Chronic non-bacterial osteomyelitis (CNO) is a rare condition characterized by inflammatory bone lesions with no detectable infectious agents. It may be unifocal (U-CNO) or…
  • Abstract Number: 2035 • 2012 ACR/ARHP Annual Meeting

    Performance of Icbd (International Criteria for Behcet’s Disease) in Iranian Children with Behcet’s Disease

    Nahid Shafaie1, Bahar Sadeghi Abdollahi2 and Fereydoun Davatchi2, 1Rheumatology Research Centre, Shariati Hospital-Tehran Univ, Tehran, Iran, 2Rheumatology, Behcet's Unit, Rheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran

    Background/Purpose: ICBD is the new international criteria for diagnosis/classification of Behcet’s Disease, created in 2006. The scoring system for ICBD depends on 2 points for…
  • Abstract Number: 2036 • 2012 ACR/ARHP Annual Meeting

    Children’s Hospital of Pittsburgh Pediatric Onset En Coup De Sabre and Parry-Romberg Syndrome Cohort

    Kristin M. Brown1, Darren Smith2, Christina Kelsey3, Katherine Kurzinski4 and Kathryn S. Torok5, 1Pediatric Rheumatology, University of Pittsburgh, Pittsburgh, PA, 2Plastic and Reconstructive Surgery, university of Pittsburgh Division of Plastic and Reconstructive Surgery, Children's Hospital of Pittsburgh, Pittsburgh, 3Pediatric Rheumatology, Univ of Pittsburgh Med Ctr, Pittsburgh, PA, 4Pediatric Rheumatology, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA, 5Pediatric Rheumatology, Scleroderma Center of Pittsburgh, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA

    Background/Purpose: Localized scleroderma is an autoimmune disease characterized by disfiguring thickening and fibrosis of the skin and underlying soft tissues; the majority of cases have…
  • Abstract Number: 2037 • 2012 ACR/ARHP Annual Meeting

    Poor Quality of Gout Care Is Strongly Associated with Higher Gout-Related Health Care Utilization

    Jasvinder A. Singh1 and Joshua Richman2, 1Department of Medicine, University of Alabama, Tuscaloosa, AL, 2Biostatistics, UAB School of Medicine, Birmingham, AL

    Background/Purpose:   Proponents of improving quality of gout care have suggested various gout quality indicators, but no study to date has shown the link between…
  • Abstract Number: 2039 • 2012 ACR/ARHP Annual Meeting

    Uveitis Surveillance Through Lean-Six Sigma for Quality Assurance in Juvenile Idiopathic Arthritis

    Anjali Patwardhan1, Kelly Kelleher2, Jeffery Hoffman3, Karla B. Jones4, Stacy P. Ardoin5 and Charles H. Spencer6, 1Pediatric Rheumatology, Nationwide Childrens Hospital, Columbus, OH, 2Pediatric Research and innovation, Nationwide Childrens Hospital, Columbus, OH, 3Emergency Medicine, Nationwide Childrens Hospital, Columbus, OH, 4Rheumatology ED260- 2S, Nationwide Children's Hospital, Columbus, OH, 5Pediatric & Adult Rheumatology, Ohio State University College of Medicine, Columbus, OH, 6Rheumatology, Nationwide Childrens Hospital, Columbus, OH

    Background/Purpose:  Chronic asymptomatic iridocyclitis occurs in 10-20% of all patients with JIA leading to insidious but progressive morbidity and possible blindness. Patients with JIA-associated uveitis…
  • Abstract Number: 2040 • 2012 ACR/ARHP Annual Meeting

    Provisions of Quality Driven Care in Childhood-Onset Systemic Lupus Erythematosus

    Matthew C. Hollander1, Jessica M. Sage2, Alexandria J. Greenler2, Tadej Avcin3, Michael W. Beresford4, Graciela Espada5, Marisa S. Klein-Gitelman6, Michael Henrickson7, Tsz-Leung Lee8, Joshua D. Pendl9, Marilynn G. Punaro10, Jennifer L. Huggins11, Anne M. Stevens12 and Hermine Brunner11, 1Division of Rheumatology, Seattle Children's Hospital, Seattle, WA, 2Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 3International Investigator Consortium for MAS Diagnostic Criteria, Ljubljana, Slovenia, 4Paediatric Rheumatology, Alder Hey Children's NHS Foundation Trust, Liverpool, United Kingdom, 5Rheumatology Section, Childrens Hosp Ricardo Gutierrez, Buenos Aires, Argentina, 6Division of Rheumatology, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, 7MLC 4010, Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 8Paediatrics and Adolescent Med, Queen Mary Hospital, Hong Kong, Hong Kong, 9Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 10Pediatric Rheumatology, Texas Scottish Rite Hospital, Dallas, TX, 11Pediatric Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 12Pediatrics, University of Washington, Seattle, WA

    Background/Purpose:  Quality Indicators (QI) are retrospectively measurable elements of practice performance for which there is evidence or consensus that can be used to assess the…
  • Abstract Number: 2000 • 2012 ACR/ARHP Annual Meeting

    Whole Body Magnetic Resonance Imaging in Evaluation of Enthesitis in Spondyloarthropathy

    Hemalatha Srinivasalu1, Suvimol C. Hill2, Gina A. Montealegre Sanchez3, April D. Brundidge3, Michael M. Ward4 and Robert A. Colbert3, 1Rheumatology, NIAMS NIH, Bethesda, MD, 2Radiology and Imaging Sciences, NIH Clinical Center, Bethesda, MD, 3NIAMS NIH, Bethesda, MD, 4Bldg 10 CRC Rm 4-1339, NIAMS NIH, Bethesda, MD

    Background/Purpose: Enthesitis is a characteristic feature of spondyloarthritis (SpA). Tenderness at enthesial points constitutes clinical enthesitis. However, this may not always correlate with actual inflammation…
  • Abstract Number: 2001 • 2012 ACR/ARHP Annual Meeting

    Methotrexate and Injectable Tumor Necrosis Factor Alpha Inhibitor Adherence and Persistence in Children with Rheumatic Diseases

    Sarah Ringold1, Shannon Grant2, Charmaine Girdish3, Carol A. Wallace4 and Sean Sullivan5, 1Pediatrics, Seattle Children's Hospital/Univ of Washington, Seattle, WA, 2Axio Research LLC, Seattle, WA, 3Research, CVS Caremark, Scottsdale, AZ, 4Pediatrics, Seattle Childrens Hospital, Seattle, WA, 5Health Sciences Building, University of Washington, Seattle, WA

    Background/Purpose: Medication adherence and persistence have been demonstrated to have important implications for treatment effectiveness, cost, and safety. Methotrexate is one of the most commonly…
  • Abstract Number: 2002 • 2012 ACR/ARHP Annual Meeting

    Randomized Clinical Trial in Pediatric Rheumatology: Are Parents and Patients in Equipoise?

    Petra C.E. Hissink Muller1, Bahar Yildiz1, Cornelia F. Allaart2, Danielle M.C. Brinkman3, Marion A. J. Van Rossum4, J. Merlijn Van den Berg5, Lisette W.A. Van Suijlekom-Smit6, Rebecca Ten Cate1 and Martine C. de Vries7, 1Pediatric Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 3Pediatric Rheumatology, Rijnland Hospital, Leiderdorp, Netherlands, 4Department of Pediatric Rheumatology and Immunology, Emma Children's Hospital / Academic Medical Center and Reade Institute, Amsterdam, Netherlands, 5Pediatric Rheumatology, Emma Children's Hospital / Academic Medical Centre and Reade Institute, Amsterdam, Netherlands, 6Pediatric Rheumatology, Erasmus MC Sophia Children's Hospital, Rotterdam, Netherlands, 7Medical Ethics and Health Law, Leiden University Medical Center, Leiden, Netherlands

    Background/Purpose: It is an ethical requirement for setting up a randomized controlled trial (RCT) that the physician-investigator must have genuine uncertainty about the therapeutic options.…
  • Abstract Number: 2003 • 2012 ACR/ARHP Annual Meeting

    Colchicine As a Therapeutic Option in Periodic Fever Aphtous  Stomatitis, Pharingitis Syndrome.   and Cervical Adenitis (PFAPA)

    Yonatan butbul Aviel1, Sameh Tatour2, Ruth Gershoni3 and Riva Brik4, 1Pediatric Rheumatology, Rambam Medical Center, Haifa, Israel, 2Pediatric Unit B, Rambam Medical Center, Israel, 3Genetics Unit, Rambam, Israel, 4Pediatric Unit B, Rambam Medical center

    Background/Purpose: PFAPA syndrome is episodic  disease characterized by periodic episodes of high fever, aphthous stomatitis, pharyngitis, and cervical adenitis, so far no therapy was shown…
  • Abstract Number: 2004 • 2012 ACR/ARHP Annual Meeting

    Do We Need a Minimum Standards in Care for Children with Localized Scleroderma- Result of the Consensus Meeting in Hamburg Germany On the 11th of December 2011. Part I. Diagnosis and Assessment of the Disease

    Ivan Foeldvari1, Tamás Constantin2, Peter Hoeger3, Monika Moll4, Clare Pain5, Dana Nemcova6, Kathryn S. Torok7, Lisa Weibel8 and Philip J. Clements9, 1Kinder- und Jugenrheumatologie, Hamburger Zentrum Kinder-und Jugendrheumatologie, Hamburg, Germany, 2Pediatric Rheumatology, Semmelweis Egyetem, AOK, II.sz. Gyermekgyogyaszati Klinika, Budapest, Hungary, 3Pediatric Dermatology, Kinderkrankenhaus Wilhelmstift, Hamburg, Germany, 4Pediatric Rheumatology, University Childrenxsxhospital, Tübingen, Germany, 5Paediatric Rheumatology, Alder Hey Children's Hospital, Liverpool, United Kingdom, 6Pediatric Rheumatology, University Childrenxsxhospital, Prague, Czech Republic, 7Pediatric Rheumatology, Scleroderma Center of Pittsburgh, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA, 8Pediatric Dermatology, University Childrenxs Hospital, Zurich, Switzerland, 9University of California, Los Angeles, Department of Medicine, Los Angeles, CA

    Background/Purpose: Juvenile localised scleroderma (jlSc) is an orphan disease. There are currently no guidelines regarding diagnosis, follow up and treatment. In the frame of the…
  • Abstract Number: 2005 • 2012 ACR/ARHP Annual Meeting

    Clinical Course and Outcomes of Children with Juvenile Idiopathic Arthritis-Associated Uveitis and Idiopathic Uveitis

    Sheila T. Angeles-Han1, Steven Yeh2, Courtney McCracken3, Larry B. Vogler4, Kelly A. Rouster-Stevens5, Christine W. Kennedy6, Matthew Kent4, Kirsten Jenkins7, Scott Lambert8, Carolyn Drews-Botsch9 and Sampath Prahalad10, 1Pediatrics, Emory Univ School of Medicine, Atlanta, GA, 2Ophthalmology, Emory University School of Medicine, Atlanta, GA, 3Emory University School of Medicine, Atlanta, GA, 4Dept of Pediatrics, Emory Univ School of Medicine, Atlanta, GA, 5Pediatric Rheumatologist, Emory Children's Center, Atlanta, GA, 6Rheumatology Immunology, Emory Children's Center, Atlanta, GA, 7Children's Healthcare of Atlanta, Atlanta, GA, 8Ophthalmology, Emory Univ School of Medicine, Atlanta, GA, 9Epidemiology, Emory University School of Public Health, Atlanta, GA, 10Pediatrics, Emory Children's Center, Atlanta, GA

    Background/Purpose:  Uveitis can lead to vision loss and blindness.  Few studies focus on the outcomes of children with both juvenile idiopathic arthritis-associated uveitis (JIA-U) and…
  • Abstract Number: 2006 • 2012 ACR/ARHP Annual Meeting

    Sexual Health and Substance Abuse in Adolescents with Rheumatic Conditions

    Sara M. Stern1, Rhina Castillo2, Katherine AB Marzan2, Jennifer Jackson3, Mona Desai3, Ellen Iverson3, Leslie F. Clark3 and Diane Tanaka3, 1Pediatric Rheumatology, Children's Hospital Los Angeles, Los Angeles, CA, 2Division of Rheumatology, Children's Hospital Los Angeles, Los Angeles, CA, 3Division of Adolescent Medicine, Children's Hospital Los Angeles, Los Angeles, CA

    Background/Purpose: Adolescence is a unique stage with pubertal maturation, individuation from parents and peer group identification.  The impact of a rheumatic condition can affect social,…
  • Abstract Number: 2007 • 2012 ACR/ARHP Annual Meeting

    Radiological Peripheral Involvement At Hands, Feet and Hips in Young Adults with Polyarticular Idiopathic Juvenile Arthritis

    Muriel Elhai1, Ramin Bazeli2, Veronique Freire2, Antoine Feydy2, Andre Kahan3, Chantal Job-Deslandre4 and Julien Wipff1, 1Rheumatology A, Paris Descartes University, Cochin Hospital, APHP, Paris, France, 2Radiology B, Paris Descartes University, Cochin Hospital, APHP, Paris, France, 3Service de Rhumatologie A, Rheumatology A, Paris Descartes University, Cochin Hospital, APHP, Paris, France, 4Service de Rhumatologie, Rheumatology A, Paris Descartes University, Cochin Hospital, APHP, Paris, France

    Background/Purpose: Radiographic damage was recently considered to be a feature of poor prognosis in cases of polyarticular juvenile idiopathic arthritis (pJIA). However, most radiographic studies…
  • « Previous Page
  • 1
  • …
  • 2467
  • 2468
  • 2469
  • 2470
  • 2471
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology